Almost all the included studies, and most importantly, the higher quality studies like RAINBOW [6], agreed that LPC treatment leads to greater refractive errors and greater rates of myopia than intravitreal anti-VEGF treatment modalities. This evidence concerns the gene VEGFA and myopia.